Yangzhou Chenhua(SZ:300610) Zheng Quan Zhi Xing·2025-05-09 07:09Core Viewpoint - The company, Chenghua Co., Ltd., is actively engaged in the surfactant industry, focusing on high-performance new materials and expanding its product offerings in response to market demands and technological advancements [2][9]. Industry Overview - The surfactant industry in China has developed into a large-scale sector with a wide variety of products. The industry is moving towards functionalization and greening, with significant advancements in key technologies and production processes [2]. - There are few listed companies in China that primarily produce alkyl glycosides and polyether amines, indicating a niche market with high technical requirements [2]. Company Structure and Subsidiaries - The company has established a subsidiary, Jiangsu Dajiang New Materials Chemical Co., Ltd., in partnership with Dajiang Chemical, focusing on polyurethane catalysts and epoxy resin curing agents. The registered capital is 150 million RMB, with the company holding a 50.1% stake [3]. Trade Impact - The company has been enhancing its export efforts, with a diversified customer base primarily in Southeast Asia and the EU. The impact of the US-China trade war on the company is minimal, as exports to the US represent a small portion of total sales [4]. Production Capacity and Utilization - The current production capacity for polyether amines is 31,000 tons per year, with a utilization rate of 28,500 tons per year. The specific capacity utilization for the wind power product D230 has increased from 2,500 tons per year in January to 5,000 tons per year since mid-April [5][6]. Research and Development - The company is focusing on several key R&D projects, including the development of efficient clean fire extinguishing agents, new decolorization processes for alkyl glycosides, and methods for continuous preparation of silicone oil [7][8]. Profit Growth Expectations - For 2025, the company anticipates profit growth through innovation in polyether amine applications, expansion of alkyl glycoside production capacity, and potential recovery in the chemical industry [9]. Financial Performance - In the first quarter of 2025, the company reported a main revenue of 216 million RMB, a year-on-year decrease of 4.32%. However, the net profit attributable to shareholders increased by 23.05% to 27.02 million RMB [10].